Quest Diagnostics: Success Through Tests

Filed under: Stocks to Buy

Quest Diagnostics' stock (DGX), which I first wrote about on June 25, 2009 at a price of $55.89, has risen and fallen in roller-coaster fashion lately, with technical indicator violations, but the business model still looks attractive. Here's why.



Without question, Quest would benefit from health care reform at the federal level, if it occurs. Congressional Democrats were poised on Friday, March 12 to begin the reconciliation process for a bill that could produce health care reform... or nothing, after 15 months of debate: the bill's fate remains undermined.

Continue reading Quest Diagnostics: Success Through Tests

Quest Diagnostics: Success Through Tests originally appeared on BloggingStocks on Fri, 12 Mar 2010 17:40:00 EST. Please see our terms for use of feeds.

Permalink | Email this | Comments

Full story at http://www.pheedcontent.com/click.phdo?i=67f55cf894f1d3fa2861286e452d2157